Evaluation of Bupivacaine and Dexamethasone effect on Post Tonsillectomy Pain reduction

Evaluation of peritonsillar infiltration of Bupivacaine and Dexamethasone effect on pediatric post tonsillectomy pain reduction

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190406043179N1

Enrollment

Registered

2019-08-05

Start date

2019-07-21

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric post tonsillectomy pain.

Interventions

Intervention 1: Intervention group: there are 35 of attended patients (according to the criteria of entering the study), who they will receive Bupivacaine 5 mg (?France Astra Zeneca company) with Dexa

Eligibility

Sex/Gender

All

Age

4 Years to 15 Years

Inclusion criteria

Inclusion criteria: Tonsillectomy surgery indication Age between 4-15 years

Exclusion criteria

Exclusion criteria: Asthma Chronic analgesic drugs use Usage of analgesic drugs at 24 hours before surgery Inability to connect with others Chronic disease Peritonsillar abscess history Present upper respiratory infection

Design outcomes

Primary

Measure	Time frame
Pediatric post tonsillectomy pain,. Timepoint: 6, 12, 24 hours after surgery. Method of measurement: Using of Visual Pain Analog Scale by executor of plan.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKaveh Ghajari

Sabzevar University of Medical Sciences

kaveh.gh90@gmail.com+98 51 3765 7960

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026